12 results on '"Mark H. Pinkerton"'
Search Results
2. Protein Modifications | Biosynthesis of Selenoproteins
- Author
-
Mark H. Pinkerton and Paul R. Copeland
- Published
- 2021
- Full Text
- View/download PDF
3. Crystal structures of the human elongation factor eEFSec suggest a non-canonical mechanism for selenocysteine incorporation
- Author
-
Srinivas Chakravarthy, Zbyszek Otwinowski, Malgorzata Dobosz-Bartoszek, Miljan Simonović, Dieter Söll, Mark H. Pinkerton, and Paul R. Copeland
- Subjects
0301 basic medicine ,Science ,Protein domain ,General Physics and Astronomy ,RNA, Transfer, Amino Acyl ,Guanosine triphosphate ,Biology ,Crystallography, X-Ray ,Guanosine Diphosphate ,Protein Structure, Secondary ,Article ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,chemistry.chemical_compound ,Protein Domains ,Humans ,Selenoproteins ,Phylogeny ,Proteinogenic amino acid ,chemistry.chemical_classification ,Multidisciplinary ,Selenocysteine ,Translation (biology) ,General Chemistry ,Peptide Elongation Factors ,Elongation factor ,030104 developmental biology ,Biochemistry ,chemistry ,Guanosine diphosphate ,Protein Biosynthesis ,Codon, Terminator ,Biophysics ,Guanosine Triphosphate ,Selenocysteine incorporation ,Ribosomes - Abstract
Selenocysteine is the only proteinogenic amino acid encoded by a recoded in-frame UGA codon that does not operate as the canonical opal stop codon. A specialized translation elongation factor, eEFSec in eukaryotes and SelB in prokaryotes, promotes selenocysteine incorporation into selenoproteins by a still poorly understood mechanism. Our structural and biochemical results reveal that four domains of human eEFSec fold into a chalice-like structure that has similar binding affinities for GDP, GTP and other guanine nucleotides. Surprisingly, unlike in eEF1A and EF-Tu, the guanine nucleotide exchange does not cause a major conformational change in domain 1 of eEFSec, but instead induces a swing of domain 4. We propose that eEFSec employs a non-canonical mechanism involving the distinct C-terminal domain 4 for the release of the selenocysteinyl-tRNA during decoding on the ribosome., Specialized translation elongation factors (eEFSec and SelB) promote selenocysteine incorporation into proteins. Here, the authors report the structure of human eEFSec, examine its interactions with guanine nucleotides, and propose a non-canonical mechanism for decoding selenocysteine.
- Published
- 2016
4. In Vitro Translation Assays for Selenocysteine Insertion
- Author
-
Mark H, Pinkerton and Paul R, Copeland
- Subjects
Reticulocytes ,Cell-Free System ,RNA-Binding Proteins ,RNA, Transfer, Amino Acyl ,Recombinant Proteins ,Selenocysteine ,Genes, Reporter ,Protein Biosynthesis ,Animals ,RNA, Messenger ,Rabbits ,Selenoproteins ,3' Untranslated Regions ,Triticum - Abstract
The molecular characterization of the protein and RNA factors that are required for Sec incorporation in mammals has been largely carried out using in vitro translation systems specifically modified for this purpose. This chapter outlines the various systems and modifications that have been used to decipher the mechanism of Sec incorporation.
- Published
- 2017
5. In Vitro Translation Assays for Selenocysteine Insertion
- Author
-
Mark H. Pinkerton and Paul R. Copeland
- Subjects
0301 basic medicine ,Messenger RNA ,030102 biochemistry & molecular biology ,Selenocysteine ,Three prime untranslated region ,Mechanism (biology) ,RNA ,Translation (biology) ,In vitro ,Cell biology ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,chemistry - Abstract
The molecular characterization of the protein and RNA factors that are required for Sec incorporation in mammals has been largely carried out using in vitro translation systems specifically modified for this purpose. This chapter outlines the various systems and modifications that have been used to decipher the mechanism of Sec incorporation.
- Published
- 2017
- Full Text
- View/download PDF
6. The utilization of selenocysteine-tRNA
- Author
-
Bradley A, Carlson, Nirupama, Gupta, Mark H, Pinkerton, Dolph L, Hatfield, and Paul R, Copeland
- Subjects
Short Article - Abstract
The tRNA for the 21st proteinogenic amino acid, selenocysteine, exists in mammalian cells as 2 isoforms differing by a single 2′-O-methylribosyl moiety at position 34 (Um34). These isoforms contain either 5-methoxycarbonylmethyluridine (mcm5U) or 5-methoxycarbonylmethyl-2′-O-methyluridine (mcm5Um) at position 34. The accumulation of the mcm5Um isoform is tightly correlated with the expression of nonessential “stress response” selenoproteins such as glutathione peroxidase 1 (GPX1). The expression of essential selenoproteins, such as thioredoxin reductase 1 (TXNRD1), is not affected by changes in Sec-tRNA[Ser]Sec isoform accumulation. In this work we used purified mcm5U and mcm5Um Sec-tRNA[Ser]Sec isoforms to analyze possible differences in binding to the selenocysteine-specific elongation factor, EEFSEC, and the translation of GPX1 and TXNRD1 in vitro. Our results indicate that no major distinction between mcm5U and mcm5Um isoforms is made by the translation machinery, but a small consistent increase in GPX1 translation is associated with the mcm5Um isoform. These results implicate fundamental differences in translation efficiency in playing a role in regulating selenoprotein expression as a function of isoform accumulation.
- Published
- 2017
7. Eukaryotic Mechanisms of Selenocysteine Incorporation and Its Reconstitution In Vitro
- Author
-
Paul R. Copeland and Mark H. Pinkerton
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,integumentary system ,030102 biochemistry & molecular biology ,Selenocysteine ,Selenoprotein P ,Translation (biology) ,Ribosomal RNA ,Ribosome ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,chemistry ,Biochemistry ,Selenoprotein ,Selenocysteine incorporation ,Eukaryotic Ribosome - Abstract
Selenocysteine (Sec) incorporation requires the highly choreographed interplay between a multitude of factors and the elongating eukaryotic ribosome. This chapter focuses on the mechanism by which the known factors deliver Sec-tRNA[Ser]Sec to the ribosomal A-site for both the single Sec incorporation events required for most selenoproteins as well as multiple Sec incorporation events required for the synthesis of Selenoprotein P. The role that in vitro translation systems has played in the determination of these mechanisms is highlighted.
- Published
- 2016
- Full Text
- View/download PDF
8. Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis
- Author
-
Timothy M. Block, Xuanyong Lu, Mark H. Pinkerton, Jason Lamontagne, Felix Lu, and Angela Sun
- Subjects
Serine protease ,Cytolytic granule ,biology ,medicine.medical_treatment ,Immunology ,Immunotherapy ,Granzyme ,Apoptosis ,Cancer cell ,medicine ,Granzyme A ,biology.protein ,Cancer research ,Immunology and Allergy ,Cytotoxic T cell - Abstract
Serine protease inhibitor Kazal (SPIK) is an inflammatory protein whose levels are elevated in numerous cancers. However, the role of this protein in cancer development is unknown. We have recently found that SPIK suppresses serine protease-dependent cell apoptosis. Here, we report that anti-SPIK antibodies can co-immmunoprecipitate serine protease granzyme A (GzmA), a cytolytic granule secreted by cytotoxic T lymphocytes and natural killer cells during immune surveillance, and that SPIK suppresses GzmA-induced cell apoptosis. Deletion studies show that the C3-C4 region of SPIK is critical for this suppression. These studies suggest that over-expression of SPIK may prevent GzmA-mediated immune-killing, thereby establishing the tolerance of cancer cells to the body's immune surveillance system. Suppression of over-expressed SPIK can restore the susceptibility of these cells to apoptotic death triggered by GzmA. This finding implies that it is possible to overcome tolerance of cancer cells to the body's immune surveillance system and restore the GzmA-mediated immune-killing by suppressing the over-expression of SPIK.
- Published
- 2011
- Full Text
- View/download PDF
9. The utilization of selenocysteine-tRNA[Ser]Secisoforms is regulated in part at the level of translationin vitro
- Author
-
Dolph L. Hatfield, Nirupama Gupta, Bradley A. Carlson, Paul R. Copeland, and Mark H. Pinkerton
- Subjects
0301 basic medicine ,Proteinogenic amino acid ,chemistry.chemical_classification ,Gene isoform ,TRNA modification ,GPX1 ,030102 biochemistry & molecular biology ,Selenocysteine ,Translation (biology) ,Cell Biology ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,chemistry ,Transfer RNA ,Selenoprotein ,Molecular Biology ,Developmental Biology - Abstract
The tRNA for the 21st proteinogenic amino acid, selenocysteine, exists in mammalian cells as 2 isoforms differing by a single 2'-O-methylribosyl moiety at position 34 (Um34). These isoforms contain either 5-methoxycarbonylmethyluridine (mcm5U) or 5-methoxycarbonylmethyl-2'-O-methyluridine (mcm5Um) at position 34. The accumulation of the mcm5Um isoform is tightly correlated with the expression of nonessential "stress response" selenoproteins such as glutathione peroxidase 1 (GPX1). The expression of essential selenoproteins, such as thioredoxin reductase 1 (TXNRD1), is not affected by changes in Sec-tRNA[Ser]Sec isoform accumulation. In this work we used purified mcm5U and mcm5Um Sec-tRNA[Ser]Sec isoforms to analyze possible differences in binding to the selenocysteine-specific elongation factor, EEFSEC, and the translation of GPX1 and TXNRD1in vitro. Our results indicate that no major distinction between mcm5U and mcm5Um isoforms is made by the translation machinery, but a small consistent increase in GPX1 translation is associated with the mcm5Um isoform. These results implicate fundamental differences in translation efficiency in playing a role in regulating selenoprotein expression as a function of isoform accumulation.
- Published
- 2017
- Full Text
- View/download PDF
10. Combined Genomics and Experimental Analyses of Respiratory Characteristics of Shewanella putrefaciens W3-18-1
- Author
-
Jizhong Zhou, Yunfeng Yang, Zhili He, Jingrong Chen, Qichao Tu, Dongru Qiu, Yili Liang, Hehong Wei, Ming Xie, and Mark H. Pinkerton
- Subjects
Anaerobic respiration ,Hydrogenase ,Nitrates ,Ecology ,Periplasmic space ,Bacterial genome size ,Shewanella putrefaciens ,Biology ,Fumarate reductase ,biology.organism_classification ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Microbiology ,Electron Transport ,Oxygen ,Biochemistry ,medicine ,Environmental Microbiology ,Escherichia coli ,Oxidation-Reduction ,Prophage ,Metabolic Networks and Pathways ,Food Science ,Biotechnology - Abstract
It has previously been shown that the Shewanella putrefaciens W3-18-1 strain produces remarkably high current in microbial fuel cells (MFCs) and can form magnetite at 0°C. To explore the underlying mechanisms, we developed a genetic manipulation method by deleting the restriction-modification system genes of the SGI1 ( Salmonella genome island 1)-like prophage and analyzed the key genes involved in bacterial respiration. W3-18-1 has less respiratory flexibility than the well-characterized S. oneidensis MR-1 strain, as it possesses fewer cytochrome c genes and lacks the ability to oxidize sulfite or reduce dimethyl sulfoxide (DMSO) and timethylamine oxide (TMAO). W3-18-1 lacks the hydrogen-producing Fe-only hydrogenase, and the hydrogen-oxidizing Ni-Fe hydrogenase genes were split into two separate clusters. Two periplasmic nitrate reductases (NapDAGHB and NapDABC) were functionally redundant in anaerobic growth of W3-18-1 with nitrate as the electron acceptor, though napDABC was not regulated by Crp. Moreover, nitrate respiration started earlier in W3-18-1 than in MR-1 (with NapDAGHB only) under microoxic conditions. These results indicate that Shewanella putrefaciens W3-18-1 is well adapted to habitats with higher oxygen levels. Taken together, the results of this study provide valuable insights into bacterial genome evolution.
- Published
- 2013
11. Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5
- Author
-
Ronaldo Paolo L, Panganiban, Mark H, Pinkerton, Saumya Y, Maru, Sarah J, Jefferson, Alanna N, Roff, and Faoud T, Ishmael
- Subjects
Original Article - Abstract
Asthma is a chronic inflammatory disease that can be difficult to manage due to a lack of diagnostic biomarkers and an incomplete understanding of the molecular pathogenesis. MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs with increasing importance in regulation of immune function and as biomarkers. We profiled miRNAs in the serum of asthmatics and non-asthmatic controls to identify miRNAs that could serve as diagnostic markers and potential regulators of allergic inflammation. Differential expression of miR-1248, miR-26a, Let-7a, and Let-7d were observed in asthmatic patients compared to controls. Predictive algorithm analyses of these miRNAs revealed their specificity for different Th2 cytokines, including IL-5, which has not previously been shown to be post-transcriptionally regulated. Using multiple approaches, we showed that miR-1248 physically interacts with the IL-5 transcript in the 3’ untranslated region and serves as a positive regulator to increase IL-5 expression. Collectively, our results demonstrate a previously uncharacterized mode of regulation of IL-5 expression and potential use for miRNAs in the diagnosis and clinical management of asthma.
- Published
- 2012
12. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults
- Author
-
Mark H. Pinkerton, Vernon M. Chinchilli, Faoud T. Ishmael, Eric T. Harvill, Avery August, Erin Banta, Margherita T. Cantorna, Rebecca Bascom, and Timothy J. Craig
- Subjects
Adult ,Male ,medicine.medical_specialty ,business.industry ,Immunology ,MEDLINE ,Pulmonary disease ,Middle Aged ,medicine.disease ,Gastroenterology ,Asthma ,MicroRNAs ,Pulmonary Disease, Chronic Obstructive ,Breath Tests ,Forced Expiratory Volume ,Internal medicine ,microRNA ,Humans ,Immunology and Allergy ,Medicine ,Female ,Differential expression ,business - Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.